Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2019; 29 (1): 33-36
in English | IMEMR | ID: emr-202897

ABSTRACT

Objective: To differentiate between adenocarcinoma cells and reactive mesothelial cells [RMC] in serous effusions using a limited immuno-panel of Ber-EP4 and Calretinin


Study Design: Descriptive study


Place And Duration Of Study: Department of Pathology, Allama Iqbal Medical College, Lahore, in collaboration with the Departments of Surgery, Pulmonology and Oncology, Jinnah Hospital, Lahore, from March 2015 to March 2016


Methodology: Ninety-seven clinically and radiologically proven cases of peritoneal and pleural effusion and peritoneal wash of patients with suspicion of malignancy were included in the present study. Diagnostic accuracy of a limited immuno-panel of Calretinin and Ber-EP4 for diagnosis of malignant effusions was calculated using histopathology as gold standard


Results: The sensitivity of Ber-EP4 for malignant cases was 98.6%, specificity 100%, positive predictive value [PPV] 100%, negative predictive value [NPV] 96%, and diagnostic accuracy 98.9%. Sensitivity of Calretinin as positive staining for RMC was 79.2%, specificity and positive predictive value [PPV] 100%, negative predictive value [NPV] 93.6%, and diagnostic accuracy 94.8%


Conclusion: Limited immuno-panel of Calretinin and Ber-EP4 had a high positive and negative predictive value and is cost-effective in resource limited set-up for identification of adenocarcinoma cells and reactive mesothelial cells in challenging cases of serous effusions

SELECTION OF CITATIONS
SEARCH DETAIL